A perspective on dose banding
J Natl Compr Canc Netw
.
2013 Mar 1;11(3):357-9.
doi: 10.6004/jnccn.2013.0045.
Authors
Jake B Guinto
1
,
Audrea H Szabatura
Affiliation
1
Oncology Drugs & Biologics at NCCN, USA.
PMID:
23486460
DOI:
10.6004/jnccn.2013.0045
No abstract available
MeSH terms
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / economics
Cost Savings
Drug Dosage Calculations*
Humans
Neoplasms / drug therapy*
Substances
Antineoplastic Agents